Pancreatic Cancer Research

At City of Hope, we offer access to drug, surgical and other clinical trials aimed at improving survival rates and enhancing quality of life.

We are investigating a drug called PEGPH20, which may disrupt pancreatic cancer cells' ability to fight off chemotherapy by creating a barrier around tumors.

We are comparing blood samples of healthy adults and pancreatic cancer patients to search for DNA abnormalities. The goal is to design a DNA test that detect a cancer recurrence or spread at its earliest stages.

City of Hope is working on an improved supportive care program aimed at improving quality of life and the overall care experience.

Browse through our clinical trials and research projects here.